Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Operating Leases (2019 - 2025)

Updated

Sinovac Biotech's Operating Leases was $8.64 million in Q4 2025, down 34.5% from $13.2 million a year earlier.

Analysis

Sinovac Biotech (SVA) Operating Leases (2019 - 2025) Analysis & Trends

From Q4 2019 onward, Sinovac Biotech has reported Operating Leases for 7 quarters.

  • Operating Leases has now declined for four consecutive years, with a five-year compound annual growth rate of -36.8% (FY2020 to FY2025).
  • In earlier years, Operating Leases was $13.2 million in FY2024 (-66.2%), $38.99 million in FY2023 (-25.8%), $52.52 million in FY2022 (-53.3%) and $112.47 million in FY2021 (+31.6%).
  • The Q4 2025 figure marks the lowest quarterly Operating Leases since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,169.89 Bn 1,138.48 Bn 19.71 Bn
2 Johnson & Johnson 648.35 Bn 568.21 Bn 17.30 Bn
3 AbbVie 504.24 Bn 477.35 Bn 12.70 Bn
4 Merck 365.96 Bn 320.33 Bn 12.21 Bn
5 Novartis Ag 303.28 Bn 267.27 Bn 11.24 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn
7 Amgen 242.76 Bn 198.16 Bn 7.24 Bn
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn
9 Pfizer 172.99 Bn 119.64 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 8.64 Mn
Dec 31, 2024 13.20 Mn
Dec 31, 2023 38.99 Mn
Dec 31, 2022 52.52 Mn
Dec 31, 2021 112.47 Mn
Dec 31, 2020 85.49 Mn
Dec 31, 2019 5.76 Mn
API Access

Sinovac Biotech Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=SVA&period=max&api_key=YOUR_API_KEY